Survival and end-of-life aspects among subjects on long-term noninvasive ventilation [0.03%]
长期接受无创通气患者的生存和临终问题
Heidi A Rantala,Sirpa Leivo-Korpela,Siiri Kettunen et al.
Heidi A Rantala et al.
Background: The need for noninvasive ventilation (NIV) is commonly considered a predictor of poor survival, but life expectancy may vary depending on the underlying disease. We studied the factors associated with decrease...
Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD [0.03%]
评估哮喘及慢性阻塞性肺病患者的剂量递送错误、培训时间以及患者对都保和普米克都宝的偏好程度
Jordi Giner,Marta Villarnovo Cerrillo,Jaime Aboín Sierra et al.
Jordi Giner et al.
While poor inhaler technique in asthma and chronic obstructive pulmonary disease (COPD) can compromise the effectiveness of inhaled medications, identifying and quantifying these errors may suggest ways to improve inhalation technique and p...
Automatic oxygen titration with O2matic® to patients admitted with COVID-19 and hypoxemic respiratory failure [0.03%]
O2matic自动调氧在COVID-19伴低氧性呼吸衰竭患者中的应用研究
Ejvind Frausing Hansen,Charlotte Sandau Bech,Jørgen Vestbo et al.
Ejvind Frausing Hansen et al.
Introduction: Patients with coronavirus disease (COVID-19) and pneumonitis often have hypoxemic respiratory failure and a need of supplementary oxygen. Guidelines recommend controlled oxygen, for most patients with a reco...
Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer [0.03%]
使用eFlow雾化器递送的吸入型PA101改善色甘酸钠的生物利用度
Khalid Abd-Elaziz,Hanneke Oude Elberink,Zuzana Diamant
Khalid Abd-Elaziz
In 1960s, cromolyn sodium (CS) has been introduced as the first non-steroidal anti-inflammatory drug for the treatment of allergic and mast-cell driven diseases. Its applicability has been limited due to a poor bioavailability. Here we pres...
Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality [0.03%]
特发性肺纤维化管理的变化：对疾病严重程度和死亡率的影响
Charlotte Hyldgaard,Janne Møller,Elisabeth Bendstrup
Charlotte Hyldgaard
Background: Idiopathic pulmonary fibrosis (IPF) is a serious interstitial lung disease (ILD) with a median survival of 3-5 years. The aim of the present study was to evaluate disease severity and survival in patients diag...
Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma [0.03%]
慢性阻塞性肺疾病患者急性加重与有无哮喘史的肺癌风险的关系研究
Ane Aamli Gagnat,Miriam Gjerdevik,Stein Atle Lie et al.
Ane Aamli Gagnat et al.
Rationale: There is limited knowledge on the effect of acute exacerbations in chronic obstructive pulmonary disease (AECOPD) on lung cancer risk in COPD patients with and without a history of asthma. This study aims to ex...
Evaluating the effect on asthma quality of life of added reflexology or homeopathy to conventional asthma management - an investigator-blinded, randomised, controlled parallel group study [0.03%]
在常规哮喘管理中增加反射疗法或顺势疗法对哮喘生活质量的影响的评估-研究者盲法随机对照平行组研究
Ayfer Topcu,Anders Løkke,Leila Eriksen et al.
Ayfer Topcu et al.
Background: Asthma is a common chronic disease worldwide without any known cure. Despite remarkable improvement in asthma treatment, better education and guideline implementation strategies, there is growing interest in u...
Clinical and daily respiratory care and clinical trials within the COVID-19 era [0.03%]
COVID-19大流行时期的临床和日常呼吸护理及临床试验
Zuzana Diamant,Vibeke Backer,Leif Bjermer
Zuzana Diamant
Indumathi Kumarathas,Torben Harsløf,Charlotte Uggerhøj Andersen et al.
Indumathi Kumarathas et al.
It is well-known that use of continuous systemic corticosteroids (SG) affects bone metabolism, bone mineral density (BMD), and ultimately increases the risk of osteoporosis. In patients with asthma, on the other hand, the effects of long-te...
Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis [0.03%]
急性COPD加重期间的升高的血液嗜酸性粒细胞：较好的短期和长期预后
Ajmal Jabarkhil,Mia Moberg,Julie Janner et al.
Ajmal Jabarkhil et al.
Background: Elevated eosinophils in COPD is recognized as a potential risk factor for exacerbations, but the prognostic role of elevated eosinophils during exacerbations of COPD is unclear. We investigated short-term and long-term outcomes ...